NCT06583967

Brief Summary

The aim of this study is to examine the effects of aerobic exercise training using an elliptical trainer compared to a treadmill on gait and walking abilities, expressed in dynamic stability, balance, and walking speed, in people with Multiple Sclerosis with moderate severity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 27, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 4, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

January 7, 2026

Status Verified

August 1, 2024

Enrollment Period

9 months

First QC Date

August 27, 2024

Last Update Submit

January 4, 2026

Conditions

Keywords

AerobicExerciseElliptical trainerTreadmill6 Minute Walk Test (6MWT)Timed Up & Go (TUG)Berg Balance Scale (BBS)10 Meter Walk Test (10MWT)Informed Consent Form (ICF)

Outcome Measures

Primary Outcomes (1)

  • Quality of life outcomes

    Quality of life to be assessed by using a Short-form 36 health status questionnaire (SF-36). SF-36 consists of 36 questions in total. Each participant will be asked to fill in the questionnaire alone and by reading it themselves.

    Baseline (screening), T1 (Week 6), T2 (Week 12), T3 (Follow-up, 6 weeks post T2)

Secondary Outcomes (4)

  • 6 Minute Walk Test (6MWT)

    Baseline (screening), T1 (Week 6), T2 (Week 12), T3 (Follow-up, 6 weeks post T2)

  • Timed Up & Go (TUG)

    Baseline (screening), T1 (Week 6), T2 (Week 12), T3 (Follow-up, 6 weeks post T2)

  • Berg Balance Scale (BBS)

    Baseline (screening), T1 (Week 6), T2 (Week 12), T3 (Follow-up, 6 weeks post T2)

  • 10 Meter Walk Test (10MWT)

    Baseline (screening), T1 (Week 6), T2 (Week 12), T3 (Follow-up, 6 weeks post T2)

Study Arms (2)

Group 1 - Elliptical Trainer

EXPERIMENTAL

15 MS subjects will be enrolled and assigned to group 1 and to be trained (Elliptical Trainer) twice a week for 12 weeks.

Other: Physical Training

Group 2 - Treadmill

EXPERIMENTAL

15 MS subjects will be enrolled and assigned to group 2 and to be trained (Treadmill) twice a week for 12 weeks.

Other: Physical Training

Interventions

Group 1 - Elliptical Trainer Group 2 - Treadmill

Group 1 - Elliptical TrainerGroup 2 - Treadmill

Eligibility Criteria

Age25 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients signed Informed Consent Form
  • At least 6 months post MS diagnosis
  • years old adults
  • EDSS 3.0-6.5
  • Standing stability - for at least 30 seconds
  • MWT - minimal distance to be measured as 210 meters
  • No physical routinely training e.g. walking, elliptical or cycling within 3 months prior screening visit.

You may not qualify if:

  • Active Heart Disease
  • Lungs and/or respiratory system diseases
  • Metabolic Disease
  • Any other medical condition(s) which might impact the patient's participant in the study, as per PI medical judgement
  • Major medical treatment change (as per PI medical judgement) up to 12 weeks prior ICF signature by the patient.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Soroka Medical Center

Beersheba, Israel, 8410101, Israel

Location

Israel ParaSport Center

Ramat Gan, Israel, 52535, Israel

Location

MeSH Terms

Conditions

Multiple SclerosisMotor Activity

Interventions

Physical Conditioning, Human

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesBehavior

Intervention Hierarchy (Ancestors)

ExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Iuly Treger, MD, PhD

    Soroka University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The study will assess the effect of 12 weeks of aerobic exercise on an elliptical trainer (group 1) vs a treadmill (group 2), on gait and walking abilities, expressed in dynamic stability, balance and walking speed, in people with Multiple Sclerosis.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Head of Rehabilitation Department

Study Record Dates

First Submitted

August 27, 2024

First Posted

September 4, 2024

Study Start

June 1, 2024

Primary Completion

February 28, 2025

Study Completion

June 30, 2025

Last Updated

January 7, 2026

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

There isn't any plan to make IPD available to other researchers.

Locations